Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lindsay M Gurska

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|July 25, 2019
Signaling Pathways in Leukemic Stem CellsLindsay M Gurska, Kristina Ames, Kira Gritsman
Current Oncology (Toronto, Ont.)|February 24, 2023
Multisite Quality Improvement Initiative to Identify and Address Racial Disparities and Deficiencies in Delivering Equitable, Patient-Centered Care for Multiple Myeloma-Exploring the Differences between Academic and Community Oncology CentersJoseph R Mikhael, Shelby L Sullivan, Jeffrey D Carter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2022
Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative NeoplasmsLindsay M Gurska, Rachel Okabe, Alexandra Schurer, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|July 25, 2019
Signaling Pathways in Leukemic Stem CellsLindsay M Gurska, Kristina Ames, Kira Gritsman
Current Oncology (Toronto, Ont.)|February 24, 2023
Multisite Quality Improvement Initiative to Identify and Address Racial Disparities and Deficiencies in Delivering Equitable, Patient-Centered Care for Multiple Myeloma-Exploring the Differences between Academic and Community Oncology CentersJoseph R Mikhael, Shelby L Sullivan, Jeffrey D Carter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2022
Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative NeoplasmsLindsay M Gurska, Rachel Okabe, Alexandra Schurer, et al.
Pageof 1